The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients

Filip Josephson (1, 2) , Maria C. H. Andersson (1) , Leo Flamholc (3) , Magnus Gisslén (4) , Lars Hagberg (4) , Vidar Ormaasen (5) , Anders Sönnerborg (6) , Jan Vesterbacka (6) , Ylva Böttiger (1)

1 Department of Clinical Pharmacology, Division of Laboratory Medicine
2 Department of Clinical Pharmacology
3 Department of Infectious Diseases
4 Department of Infectious Diseases
5 Department of Infectious Diseases
6 Department of Infectious Diseases, Institution of Medicine

Mots clés: Atazanavir; Concentration; Effect; Efavirenz; HIV-1; Lopinavir

Filip Josephson, Maria C. H. Andersson, Leo Flamholc, Magnus Gisslén, Lars Hagberg, et al.. The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients. European Journal of Clinical Pharmacology, 2009, 66 (4), pp.349-357. ⟨10.1007/s00228-009-0763-z⟩. ⟨hal-00543001⟩